chr11-112088838-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003002.4(SDHD):​c.170-29A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0275 in 1,611,516 control chromosomes in the GnomAD database, including 5,040 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 2532 hom., cov: 32)
Exomes 𝑓: 0.019 ( 2508 hom. )

Consequence

SDHD
NM_003002.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.22

Publications

8 publications found
Variant links:
Genes affected
SDHD (HGNC:10683): (succinate dehydrogenase complex subunit D) This gene encodes a member of complex II of the respiratory chain, which is responsible for the oxidation of succinate. The encoded protein is one of two integral membrane proteins anchoring the complex to the matrix side of the mitochondrial inner membrane. Mutations in this gene are associated with the formation of tumors, including hereditary paraganglioma. Transmission of disease occurs almost exclusively through the paternal allele, suggesting that this locus may be maternally imprinted. There are pseudogenes for this gene on chromosomes 1, 2, 3, 7, and 18. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2013]
SDHD Gene-Disease associations (from GenCC):
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • pheochromocytoma/paraganglioma syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Carney-Stratakis syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • mitochondrial complex II deficiency, nuclear type 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • renal cell carcinoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • mitochondrial complex 2 deficiency, nuclear type 3
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • mitochondrial complex II deficiency
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intestinal cancer
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • mitochondrial disease
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 11-112088838-A-G is Benign according to our data. Variant chr11-112088838-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 440261.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.339 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003002.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SDHD
NM_003002.4
MANE Select
c.170-29A>G
intron
N/ANP_002993.1O14521-1
SDHD
NM_001276506.2
c.170-29A>G
intron
N/ANP_001263435.1O14521-4
SDHD
NM_001276504.2
c.53-29A>G
intron
N/ANP_001263433.1O14521-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SDHD
ENST00000375549.8
TSL:1 MANE Select
c.170-29A>G
intron
N/AENSP00000364699.3O14521-1
SDHD
ENST00000528048.5
TSL:1
c.169+865A>G
intron
N/AENSP00000436217.1O14521-3
ENSG00000255292
ENST00000532699.1
TSL:3
n.170-29A>G
intron
N/AENSP00000456434.1H3BRW5

Frequencies

GnomAD3 genomes
AF:
0.106
AC:
16101
AN:
152114
Hom.:
2501
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.343
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0497
Gnomad ASJ
AF:
0.0187
Gnomad EAS
AF:
0.00308
Gnomad SAS
AF:
0.00497
Gnomad FIN
AF:
0.00490
Gnomad MID
AF:
0.0541
Gnomad NFE
AF:
0.0118
Gnomad OTH
AF:
0.0817
GnomAD2 exomes
AF:
0.0341
AC:
8552
AN:
251018
AF XY:
0.0272
show subpopulations
Gnomad AFR exome
AF:
0.358
Gnomad AMR exome
AF:
0.0247
Gnomad ASJ exome
AF:
0.0156
Gnomad EAS exome
AF:
0.00190
Gnomad FIN exome
AF:
0.00471
Gnomad NFE exome
AF:
0.0119
Gnomad OTH exome
AF:
0.0227
GnomAD4 exome
AF:
0.0193
AC:
28183
AN:
1459284
Hom.:
2508
Cov.:
31
AF XY:
0.0179
AC XY:
12978
AN XY:
726000
show subpopulations
African (AFR)
AF:
0.365
AC:
12154
AN:
33294
American (AMR)
AF:
0.0284
AC:
1270
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0144
AC:
377
AN:
26130
East Asian (EAS)
AF:
0.00111
AC:
44
AN:
39698
South Asian (SAS)
AF:
0.00392
AC:
338
AN:
86160
European-Finnish (FIN)
AF:
0.00451
AC:
241
AN:
53414
Middle Eastern (MID)
AF:
0.0431
AC:
179
AN:
4154
European-Non Finnish (NFE)
AF:
0.0104
AC:
11548
AN:
1111540
Other (OTH)
AF:
0.0338
AC:
2032
AN:
60184
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
1084
2168
3253
4337
5421
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
606
1212
1818
2424
3030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.106
AC:
16174
AN:
152232
Hom.:
2532
Cov.:
32
AF XY:
0.103
AC XY:
7687
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.344
AC:
14272
AN:
41498
American (AMR)
AF:
0.0496
AC:
759
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0187
AC:
65
AN:
3470
East Asian (EAS)
AF:
0.00309
AC:
16
AN:
5180
South Asian (SAS)
AF:
0.00456
AC:
22
AN:
4826
European-Finnish (FIN)
AF:
0.00490
AC:
52
AN:
10620
Middle Eastern (MID)
AF:
0.0582
AC:
17
AN:
292
European-Non Finnish (NFE)
AF:
0.0118
AC:
800
AN:
68018
Other (OTH)
AF:
0.0809
AC:
171
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
576
1152
1729
2305
2881
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0355
Hom.:
317
Bravo
AF:
0.121
Asia WGS
AF:
0.0310
AC:
107
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Pheochromocytoma/paraganglioma syndrome 1 (2)
-
-
1
Mitochondrial complex 2 deficiency, nuclear type 3 (1)
-
-
1
not specified (1)
-
-
1
Pheochromocytoma (1)
-
-
1
Pheochromocytoma/paraganglioma syndrome 3 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
3.8
DANN
Benign
0.60
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9919624; hg19: chr11-111959562; API